ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,978Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 105

$3.28M Total Retail Price of All Prescriptions

Rank: 4 out of 105

266 Patients Receiving at Least One Drug in Part D
25%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 266 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

0% of this provider’s 1,317 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

51% of this provider’s prescriptions were for brand-name drugs, compared to an average of 48%.

Prescription Price

$366 was the average price of a prescription from this provider, compared to $423 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
NORVIR 437 33 1 1
REYATAZ 350 43 2 7
ISENTRESS 305 28 3 3
TRUVADA 300 12 4 2
EPZICOM 253 32 5 8
FLUCONAZOLE 197 14 6 24
GABAPENTIN 178 50 7 14
ATRIPLA 177 0 8 5
AMLODIPINE BESYLATE 173 41 9 11
SUSTIVA 171 12 10 10 22
LISINOPRIL 147 0 11 9
HYDROCODONE-ACETAMINOPHEN 147 18 S3 11 6
INTELENCE 146 0 13 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 146 0 13 12
NEXIUM 137 0 15 15
TRAMADOL HCL 135 0 16 35
HYDROCHLOROTHIAZIDE 131 25 17 16
PRAVASTATIN SODIUM 117 11 18 18
DOXYCYCLINE HYCLATE 116 53 19 19
KALETRA 111 0 20 10
VALACYCLOVIR 110 0 21 23
CITALOPRAM HBR 104 0 22 41
TRICOR 103 0 23 77
ATENOLOL 95 16 24 80
VIREAD 95 0 24 13
ATORVASTATIN CALCIUM 94 24 26 21
LEXIVA 93 12 27 37
PREZISTA 92 0 28 4
POTASSIUM CHLORIDE 89 21 29 83
IBUPROFEN 87 0 30 53
METOPROLOL TARTRATE 86 11 31 43
PROAIR HFA 81 0 32 67
RANITIDINE HCL 80 0 33 40
VIRAMUNE XR 78 0 34 116
AZITHROMYCIN 78 0 34 38
EMTRIVA 77 12 36 118
AMITRIPTYLINE HCL 77 0 R 36 54
LEVOTHYROXINE SODIUM 74 27 38 20
ZIAGEN 71 0 39 48
OMEPRAZOLE 67 13 40 29
LYRICA 66 0 41 33
FUROSEMIDE 66 33 41 27
SERTRALINE HCL 64 0 43 56
ZIDOVUDINE 63 0 44 89
PANTOPRAZOLE SODIUM 60 36 45 134
METFORMIN HCL 60 11 45 25
TRAZODONE HCL 58 0 47 50
PROMETHAZINE HCL 56 0 R 48 62
METOPROLOL SUCCINATE 55 32 49 36
LOPERAMIDE 55 0 49 66
RAMIPRIL 53 0 51 145
NIASPAN 51 0 52 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.